Anti-Addiction Efforts of Painkiller Companies Met With Yawns

August 15, 2008

I’ve been writing in Brandweek this week about companies that are reformulating opioid painkillers and the like so that they can’t be as easily abused by pill-popping addicts.

King, Purdue, Acura and Pain Therapeutics all have products in the pipeline that deliver pain medicine but make it harder for people to turn them into recreational drugs.

Here’s a couple more companies that didn’t make it into the story for space reasons:

  • Alpharma in Bridgewater, N.J., filed in June to market Embeda, a morphine sulphate that has an embedded capsule of naltrexone hydrochloride inside. If the pill is crushed, the naltrexone renders the morphine inactive. Alpharma expects approval to launch by as early as the end of this year, according to Jack Howarth, vp-investor relations.
  • And Elite Pharmaceuticals in Northvale N.J., is in late-stage trials of another naltrexone pill, this one combined with oxycodone.

The FDA seems keen on these products, so it’s surprising that these seemingly sensible developments have been met with hostility by investors. Ed over at Pharmalot detailed BioLogic Investment Research and Consulting’s finding that King and Acura’s Acurox would be a revenue deterrant. Here’s the original note.

What struck me about this topic is how Wall Street may be underestimating the desire of the public to see these drugs get to market. Some anecdotal evidence: My story on Brandweek was one of the most-read stories this week, and if you look at the comments section you’ll see that parents are very passionate about the need for companies to pull their heads out of the sand when it comes to medicine abuse.

This is an issue that crosses the OTC line — down the road, I predict much PR pain coming toward Shering-Plough regarding its position that Coricidin HBP should remain on drugstore shelves and not go behind the counter with its harder-to-abuse neighbor, Sudafed.

Advertisements

2 Responses to “Anti-Addiction Efforts of Painkiller Companies Met With Yawns”

  1. Detoxer Says:

    The truth is that much of these narcotics are being used to replace street drugs. If the drug companies were forced to reformulate then to preven their being used for recreational purposes, it would reduce their sales and hence their profits.

    These drug companies know what they are doing. To think otherwise is fooling ourselves.

    The only advantage to reformulating their drug will be if they are the only one and doctors start to use their product over others.

    Steve Hayes
    Director
    http://novusdetox.com

  2. drugs med Says:

    Very interesting article, anywhere before anything like this unreadable, is rarely found in the network once again want to thank the sponsors, thank you!


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: